Ferrumal - Plus (Capsules) Instructions for Use

Marketing Authorization Holder

Pharmgroup, LLC (Russia)

Contact Information

PHARMGROUP LLC (Dietary Supplement) (Russia)

Dosage Form

Ferrumal – Plus

Capsules

Dosage Form, Packaging, and Product Composition

Composition ferrous sulfate heptahydrate, ascorbic acid, glucose, paraffin, beeswax.

Content of biologically active substances iron not less than 8 mg, vitamin C not less than 27 mg.

Dosage form and packaging
Capsules of 0.2 g.

Therapeutic Category

Dietary supplement – additional source of iron

Scope of Application

Of the Ferrumal – Plus product

Recommended as a dietary supplement – an additional source of iron and vitamin C.

Indications

• Use as an additional dietary source of iron and vitamin C to address deficiencies.
• Intended for adults who require supplemental iron intake.
• Employ to support conditions where increased iron and ascorbic acid levels are beneficial.

ICD codes

Dosage Regimen

Take one capsule orally three times daily with meals to enhance iron absorption and minimize potential gastrointestinal discomfort.

Adhere strictly to the recommended dosage; do not exceed it. The standard course of administration is one month. This is not a medicine.

Adverse Reactions

Gastrointestinal disturbances such as nausea, epigastric pain, constipation, or diarrhea may occur. These effects are often dose-dependent.

Allergic reactions, including skin rash, itching, or urticaria, are possible in individuals with hypersensitivity. Discontinue use immediately if any adverse reactions manifest.

Drug Interactions and Concomitant Use Precautions

Iron can reduce the absorption of tetracyclines, fluoroquinolones, levodopa, levothyroxine, and bisphosphonates; administer these agents at least 2 hours apart.

Ascorbic acid may increase the absorption of iron. Vitamin C can alter urinary glucose tests and potentially interact with anticoagulants like warfarin. Concurrent use with antacids may decrease iron absorption.

Contraindications and Conditions Prohibiting Use

• Contraindicated in cases of known hypersensitivity or individual intolerance to any component of the formulation, including ferrous sulfate or ascorbic acid.
• Do not use during pregnancy or while breastfeeding due to potential risks.
• Avoid use in patients with hemochromatosis, hemosiderosis, or other iron overload disorders.

Overdose Symptoms and Management Procedures

Symptoms of overdose may include abdominal pain, nausea, vomiting, diarrhea, and lethargy, which can progress to metabolic acidosis, coagulopathy, hepatic necrosis, and cardiovascular collapse.

Seek immediate medical attention in case of suspected overdose. Treatment is supportive and may include gastric lavage and administration of chelating agents such as deferoxamine in severe cases.

Dispensing Status

Available to the public through pharmacy networks and specialized stores, departments of the retail chain.

Storage Conditions

Store in a dry, light-protected place, out of reach of children, at a temperature not exceeding 25°C (77°F).

Shelf Life

Shelf life – 2 years.

Important Safety Information

This information is for educational purposes only and does not replace professional medical advice. Always consult your doctor before use. Dosage and side effects may vary. Use only as prescribed.